Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus-Reference-Cited by-同舟云学术

Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus

Published:2015-03-17 Issue:6 Volume:162 Page:407-419
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Najafzadeh Mehdi¹,Andersson Karin¹,Shrank William H.¹,Krumme Alexis A.¹,Matlin Olga S.¹,Brennan Troyen¹,Avorn Jerry¹,Choudhry Niteesh K.¹

Affiliation:

1. From Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, and Massachusetts General Hospital, Boston, Massachusetts, and CVS Health, Woonsocket, Rhode Island.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs;JAMA Health Forum;2024-04-05

2. The rising cost of rhinologic medications;Annals of Allergy, Asthma & Immunology;2023-09

3. Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels;Health Promotion Practice;2023-07-13

4. Capitalizing a Cure: How Finance Controls the Price and Value of Medicines;2023-01-24

5. Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial;Drug and Alcohol Dependence Reports;2022-12